01-May-15 Latin America's healthcare market is evolving in ways that present new opportunities for foreign firms willing to invest in the region. Four key themes driving changes are demographic shifts, chronic diseases, technology innovations and policy changes. Five key opportunities include rapid pharma sales growth, increasing dominance of generics, consolidation of pharmacies, over 16,000 hospitals, and unchallenged demand for imported med tech. [image: Global Health Intelligence]

06-May-15 China will lift price controls on most medicines starting from Jun-15, following which medicine prices will be decided by the market, the National Development & Reform Commission (NDRC) has said. Only narcotics and some listed psychotropic drugs will continue to be controlled by the government, with ceiling retail prices. [image: AFP Photo / Anthony Wallace]

06-May-15 Bayer HealthCare reaffirmed its strong position in China's healthcare industry with sales of EUR1.7 bn (USD1.9 bn) in 2014, 14% up on 2013. Its pharmaceuticals business grew at 15% in China, with a 26% spike in its consumer care business and 11% growth in its animal healthcare division. [image: China Daily]

16-Apr-15 Moody's Investors Service says that continued strong growth in China's pharmaceutical sector will mainly benefit those pharmaceutical companies that can meet heightened industry standards and market practices under the ongoing medical reform. [image: Language Connections]

08-Apr-15 According to a survey conducted by Shanghai Academy of Social Sciences and Fudan University, local residents identified long queues, unnecessary tests and expensive prescription medicines as the biggest problems with the city’s health services. [image: Shanghai Daily]